NTB Financial’s Eli Lilly LLY Stock Holding History

NTB Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$438K	Hold	1,350	–	–	0.35%	84
2022 Q1	$387K	Sell	1,350 -25	-2%	-$6.43K	0.28%	91
2021 Q4	$380K	Buy	+1,375	New	+$349K	0.27%	90

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NTB Financial's LLY Position: Q2 2022 in Review

NTB Financial held its Eli Lilly (LLY) position steady in Q2 2022 at 1,350 shares worth $438K. The position accounts for 0.35% of the portfolio, ranked #84.

NTB Financial first reported a position in LLY in Q4 2021 and has held it in 3 quarters since. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

NTB Financial held 1,350 shares of Eli Lilly worth $438K as of Q2 2022.
NTB Financial left its Eli Lilly share count unchanged in Q2 2022.
Eli Lilly made up 0.35% of NTB Financial's portfolio in Q2 2022, its #84 holding.
NTB Financial first reported a position in Eli Lilly in Q4 2021 and has held it in 3 quarters since.
2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.